Faculty

JY
Jun Yang, Ph.D., DABR
Forum Co-Chair · Janusyn / Foshan Chancheng

Director, Precision Oncology Center at Foshan Fosun Chancheng Hospital. Board-certified medical physicist; originator of the SCART framework.

AG
Angela Giselvania, M.D., Ph.D.
Forum Co-Chair · Cipto Mangunkusumo, Indonesia

Leading radiation oncologist in Indonesia; represents the broader Southeast Asia radiation oncology community.

MW
May Abdel-Wahab, M.D., Ph.D.
Director, Division of Human Health, IAEA

Leads the IAEA's global oncology programs. Speaker on IAEA SFRT Protocol on Day 2.

JD
Joanne Davis, Ph.D.
CEO, The Radiosurgery Society (RSS)

Leads the Radiosurgery Society globally; built the RSSearch Patient Registry — the largest SRS/SBRT registry managed by a professional society.

JT
Jiang Tao, Academician
Beijing Tiantan Hospital

Member of the Chinese Academy of Engineering; national authority on neuro-oncology.

XW
Xiaodong Wu, Ph.D.
President, EMPA · Miami

Holds US Patent 8,395,131 for 3D Lattice Radiotherapy. International authority on SFRT and lattice-based clinical approaches. Day 2 keynote.

JL
Jingyi Lang, M.D.
President, Sichuan Cancer Hospital

Pioneer of SFRT in China; leads multiple national clinical studies on spatially fractionated radiotherapy. Day 2 forum summary chair.

WY
Weisi Yan, M.D., Ph.D.
University of Kentucky, USA

Leads SCART clinical progress reporting; key collaborator on the Stereotactic Centralized Ablative RT framework.

SB
Seth Blacksburg, M.D., M.B.A.
Global CMO, Accuray, Inc.

International authority on CyberKnife clinical applications; delivers the pre-meeting welcome address.

JC
Jason Cheng, M.D., Ph.D.
National Taiwan University Hospital

Expert on immunological integration of radiotherapy in hepatocellular carcinoma.

MM
Maobin Meng, M.D.
Tianjin University Cancer Institute & Hospital

Leader in CyberKnife clinical applications, with particular expertise in liver SBRT. SBRT debater for the HCC creative debate.

ZY
Zhiyong Yuan, M.D.
Tianjin Tumor Hospital

Leads the Tianjin SFRT program. Discussion lead at the Asian Leader Round Table.

FW
Fu Qiang Wang, M.D.
National Cancer Centre Singapore

Leads the NCCS clinical SFRT program in liver cancer.

SD
Shisuo Du, M.D.
Zhongshan Hospital, Fudan University

Expert in liver SBRT; speaker in Session II HCC.

EW
Enmin Wang, M.D.
Janusyn Oncology · Hainan Boao BNCT

Clinical Director of the Hainan Boao BNCT program; longtime leader in stereotactic radiosurgery in China.

SG
Soehartati Gondhowiardjo, M.D., Ph.D.
Chair of Oncology, Cipto Mangunkusumo · Honor Chair

Co-founder and past president of the Federation of Asian Organizations for Radiation Oncology (FARO).

BL
Baosheng Li, M.D.
President, China Society for Radiation Oncology (CSRO)

President of CSRO; senior Chinese radiation oncologist; expert in SBRT and hypofractionation.

YY
Yidong Yang, Ph.D.
University of Science and Technology of China

Leads preclinical precision irradiation research; bridges IGRT to SFRT methodology.

BX
Benhua Xu, M.D.
Fujian Concord Hospital

Chief of Radiation Oncology; speaks on building a new particle center.

LK
Lin Kong, M.D.
President, CNMIA · Shanghai Heavy Ion Particle Hospital

President of CNMIA (Chinese Non-government Medical Institutions Association) and Chair of its Radiation Therapy Committee. Speaker on particle therapy in Shanghai.

MK
Mi-Sook Kim, M.D., Ph.D.
President, KIRAMS · Korea

President, Korea Institute of Radiological and Medical Sciences. Speaker on repeat SBRT for liver cancer.

HM
Humera Mahmood, M.D.
AECH NORI Islamabad · Pakistan

Head of Oncology at AECH NORI; Senior Vice President of the Pakistan Society of Clinical Oncology (PSCO). Speaks on both radiation oncology in Pakistan (Day 1) and Pakistani SFRT experience (Day 2).

HL
Haibo Lin, M.D.
New York Proton Center

Day 2 speaker on SFRT using proton therapy.

NC
Nonette Cupino, M.D.
University of the Philippines Manila

Day 2 speaker on the SFRT experience in the Philippines.

MS
Mostafa Sumon, M.D.
Director, NICRH · Bangladesh

Director, National Institute of Cancer Research & Hospital, Bangladesh.

JW
Jun Wang, M.D.
Fourth Hospital of Hebei Medical University

Speaker on the SFRT experience and vision of the 4th Hebei Hospital.

MZ
Min Zhao, M.D.
First Hospital of Hebei Medical University

Speaker on the SFRT experience and vision of the 1st Hebei Hospital.

QL
Qiuxia Lu, M.D.
Foshan Fosun Chancheng Hospital · Host

Speaks on Foshan Chancheng's SFRT experience; SCART clinical cases trainer at pre-meeting.

YS
Yun Shen
Fosun Health · Cross-border Oncology

Leads the concurrent international patient channels track — insurance, partnerships, and global oncology referrals.

NC
NianJi Cui, M.D.
Foshan Fosun Chancheng Hospital · Honor Chair

Former Director of the Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Honorary Chairman of this Conference.

WM
Waleed F. Mourad, M.D., Msc, DABR
University of Kentucky

He is recognized across the nation and globe for his expertise in the management of cutaneous and head and neck cancers.

WQ
WeiHua Qi, Msc
Vice President of Jinan Janusyn Cancer Hospital

Chief of Physics & Technology, Janusyn Oncology Institute, Former Medical Physicist, Alliance Healthcare Services, USA.

YD
Yang Dong
Tianjin Tumor Hospital

A top domestic CyberKnife medical physicist, specializing in precision radiotherapy treatment planning and quality assurance. He will deliver a presentation on Planning and QA Overview of CyberKnife during the Pre-meeting.

YL
Yu Li, M.D.
Chinese PLA General Hospital

Director of the Asia-Pacific CyberKnife Diagnosis, Treatment, Research and Demonstration Center for Liver Tumors, and a leading figure in China's precision radiotherapy field. He will deliver a presentation on Fiducial for Liver Cancer Treatment with CK during the Pre-meeting.

ZT
ZhenTao, M.D., Ph.D.
Director, Radiation Therapy Center & Proton Center, Tongji Hospital

Former Postdoctoral Fellow at Thomas Jefferson University Hospital, USA. He will present Particle Therapy in Wuhan on Day 1.

ZH
ZiCeng Huang, M.D.
Chancheng Hospital

With over 20 years of clinical experience in interventional therapy via both vascular and non-vascular approaches, he will deliver a presentation on Introduction of Interventional Radiology Therapy for Cancer in the Concurrent Session on Day 1.

JS
Junqi Song, Msc
Janusyn Oncology, ChanCheng Hospital

Bachelor's Degree from University of Massachusetts Amherst, Master's Degree from University of Miami. He will deliver a presentation on Process during the Pre-meeting.

HY
HongZhi Yang, M.D.
ChanCheng Hospital

Guangdong Provincial Famous Traditional Chinese Medicine (TCM) Physician. He will deliver a presentation on Introduction of Chinese Medicine and Full Disease Cycle Management on Day 1.

GY
Gang Ye, M.D.
Janusyn Oncology, ChanCheng Hospital · Chief Medical Oncologist

US-Licensed Physician in Internal Medicine, Hematology and Medical Oncology. He will deliver a presentation on Introduction of CAR-T on Day 1.